McGill researchers have developed a diagnostic system capable of identifying bacteria—and determining which antibiotics can ...

The BRILLIANT 011 trial is testing two next-generation HIV vaccine components—BG505 GT1.1 and 426c.Mod.Core-C4b—administered ...

Switching to a 2-drug ART regimen was highly effective and well tolerated in virologically suppressed patients with HIV.

Brain cells that promote tumor expansion for aggressive cancers such as glioblastoma can be “flipped” to instead inhibit that growth and potentially halt their spread, according to a study published ...

LAHORE: Two patients diagnosed with mpox have been placed in isolation at Nishtar Hospital, Multan, after laboratory tests ...

Thousands of Floridians are poised to lose access to HIV/AIDS treatment when the state’s new eligibility restrictions take ...

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in ...

Next-day HIV viral load test results do not improve overall linkage to care when added to standard testing but are tied to ...

On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.

A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical ...

Introduction Towards the ‘End TB Strategy’ targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy (TPT) for high-risk groups including people living with HIV (PLWH). 3 years ...

The project aims to develop a library of T cells with specific receptors, ultimately contributing to development of a blood test for immunological fingerprinting.